← FDA Drug Approvals (Drugs@FDA)

ETOPOSIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2001-09-19

Drug application

FDA Application #

ANDA075635

Application type

Abbreviated New Drug Application (Generic)

Brand name

ETOPOSIDE

Generic name

ETOPOSIDE

Active ingredients

ETOPOSIDE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

MYLAN

Manufacturer

Mylan Pharmaceuticals Inc.

First approval

2001-09-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown